Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 498

1.

Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness.

Schonewille H, van Rood JJ, Verduin EP, van de Watering LMG, Haasnoot GW, Claas FHJ, Oepkes D, Lopriore E, Brand A.

Haematologica. 2018 Sep 13. pii: haematol.2018.199406. doi: 10.3324/haematol.2018.199406. [Epub ahead of print]

2.

Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.

Heidt S, Haasnoot GW, van Rood JJ, Witvliet MD, Claas FHJ.

Kidney Int. 2018 Feb;93(2):491-500. doi: 10.1016/j.kint.2017.07.018. Epub 2017 Sep 22.

PMID:
28947279
3.

When selecting a cord blood unit from a firstborn donor verify that the patient shares an Ag with the unit that is foreign to the mother of the donor.

van Rood JJ, Brand A, Scaradavou A, Claas FH, Oudshoorn M, Stevens CE.

Bone Marrow Transplant. 2017 Jul;52(7):1039-1040. doi: 10.1038/bmt.2017.75. Epub 2017 Apr 24. No abstract available.

PMID:
28436971
4.

Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance.

Bracamonte-Baran W, Florentin J, Zhou Y, Jankowska-Gan E, Haynes WJ, Zhong W, Brennan TV, Dutta P, Claas FH, van Rood JJ, Burlingham WJ.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1099-1104. doi: 10.1073/pnas.1618364114. Epub 2017 Jan 17.

5.

CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.

Kooy-Winkelaar YM, Bouwer D, Janssen GM, Thompson A, Brugman MH, Schmitz F, de Ru AH, van Gils T, Bouma G, van Rood JJ, van Veelen PA, Mearin ML, Mulder CJ, Koning F, van Bergen J.

Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E980-E989. doi: 10.1073/pnas.1620036114. Epub 2017 Jan 3.

6.

Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.

Juric MK, Ghimire S, Ogonek J, Weissinger EM, Holler E, van Rood JJ, Oudshoorn M, Dickinson A, Greinix HT.

Front Immunol. 2016 Nov 9;7:470. eCollection 2016. Review.

7.

Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus.

Brugman MH, Wiekmeijer AS, van Eggermond M, Wolvers-Tettero I, Langerak AW, de Haas EF, Bystrykh LV, van Rood JJ, de Haan G, Fibbe WE, Staal FJ.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E6020-7. doi: 10.1073/pnas.1519118112. Epub 2015 Oct 19.

8.

Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.

Kosmoliaptsis V, Jöris MM, Mallon DH, Lankester AC, von dem Borne PA, Kuball J, Bierings M, Cornelissen JJ, Groenendijk-Sijnke ME, van der Holt B, Bradley JA, Oudshoorn M, van Rood JJ, Taylor CJ, Claas FH.

Bone Marrow Transplant. 2015 Apr;50(4):540-4. doi: 10.1038/bmt.2014.305. Epub 2015 Jan 26.

PMID:
25621806
9.

Half a century of Dutch transplant immunology.

van Rood JJ, Claas FH, Brand A, Tilanus MG, van Kooten C.

Immunol Lett. 2014 Dec;162(2 Pt B):145-9. doi: 10.1016/j.imlet.2014.10.017. Epub 2014 Oct 18. Review.

PMID:
25455602
10.

Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks.

Van der Zanden HG, Van Rood JJ, Oudshoorn M, Bakker JN, Melis A, Brand A, Scaradavou A, Rubinstein P.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1791-5. doi: 10.1016/j.bbmt.2014.07.011. Epub 2014 Jul 18.

11.

Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.

Eikmans M, van Halteren AG, van Besien K, van Rood JJ, Drabbels JJ, Claas FH.

Chimerism. 2014;5(2):24-39. Review.

12.

Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome.

Jöris MM, Lankester AC, von dem Borne PA, Kuball J, Bierings M, Cornelissen JJ, Sijnke ME, van der Holt B, van Rood JJ, Oudshoorn M, Claas FH.

Transpl Immunol. 2014 Mar;30(2-3):59-64. doi: 10.1016/j.trim.2013.08.006. Epub 2014 Jan 17.

PMID:
24440708
13.

Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.

Dobbelstein C, Ahn KW, Haagenson M, Hale GA, van Rood JJ, Miklos D, Waller EK, Spellman SR, Fernandez-Vina M, Ganser A, Aljurf M, Bornhaeuser M, Gupta V, Marino SR, Pollack MS, Reddy V, Eder M, Lee SJ.

Biol Blood Marrow Transplant. 2013 May;19(5):741-5. doi: 10.1016/j.bbmt.2013.01.020. Epub 2013 Feb 1.

14.

The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT.

Jöris MM, Lankester AC, von dem Borne PA, Kuball J, Bierings M, Cornelissen JJ, Groenendijk-Sijnke ME, van der Holt B, Haasnoot GW, van der Zanden HG, van Walraven SM, van Rood JJ, Claas FH, Oudshoorn M.

Bone Marrow Transplant. 2013 Apr;48(4):483-90. doi: 10.1038/bmt.2012.189. Epub 2012 Oct 15.

PMID:
23064039
15.

Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.

Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C, Baxter-Lowe LA, Baudoux E, Bergamaschi P, Chow R, Freed B, Koegler G, Kurtzberg J, Larghero J, Lecchi L, Nagler A, Navarrette C, Prasad V, Pouthier F, Price T, Ratanatharathorn V, van Rood JJ, Horowitz MM, Gluckman E, Eapen M; Eurocord-European Blood and Marrow Transplant Group and the Center for International Blood and Marrow Transplant Research.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1890-6. doi: 10.1016/j.bbmt.2012.07.010. Epub 2012 Jul 17.

16.

A proposed algorithm predictive for cytotoxic T cell alloreactivity.

Jöris MM, van Rood JJ, Roelen DL, Oudshoorn M, Claas FH.

J Immunol. 2012 Feb 15;188(4):1868-73. doi: 10.4049/jimmunol.1102086. Epub 2012 Jan 18.

17.

Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation.

van Rood JJ, Scaradavou A, Stevens CE.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2509-14. doi: 10.1073/pnas.1119541109. Epub 2012 Jan 9.

18.

Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group.

Jöris MM, Bierings MB, Egeler RM, Claas FH, van Rood JJ, Oudshoorn M.

Bone Marrow Transplant. 2012 May;47(5):677-83. doi: 10.1038/bmt.2011.168. Epub 2011 Aug 22.

PMID:
21860428
19.

AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz.

de Groot NG, Heijmans CM, Zoet YM, de Ru AH, Verreck FA, van Veelen PA, Drijfhout JW, Doxiadis GG, Remarque EJ, Doxiadis II, van Rood JJ, Koning F, Bontrop RE.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15175-80. doi: 10.1073/pnas.1009136107. Epub 2010 Aug 9.

20.

Mixed T cell receptor dimers harbor potentially harmful neoreactivity.

van Loenen MM, de Boer R, Amir AL, Hagedoorn RS, Volbeda GL, Willemze R, van Rood JJ, Falkenburg JH, Heemskerk MH.

Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10972-7. doi: 10.1073/pnas.1005802107. Epub 2010 Jun 1.

21.

Future perspectives.

van Rood JJ, Goldman JM.

Bone Marrow Transplant. 2010 May;45(5):843-5. doi: 10.1038/bmt.2010.1. Epub 2010 Feb 22. No abstract available.

PMID:
20173791
22.

Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

van Rood JJ, Stevens CE, Smits J, Carrier C, Carpenter C, Scaradavou A.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19952-7. doi: 10.1073/pnas.0910310106. Epub 2009 Nov 9.

23.

When selecting an HLA mismatched stem cell donor consider donor immune status.

van Rood JJ, Oudshoorn M.

Curr Opin Immunol. 2009 Oct;21(5):538-43. doi: 10.1016/j.coi.2009.07.016. Epub 2009 Sep 6. Review.

PMID:
19735996
24.

Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells.

Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg-V D Voort-Maarschalk M, Roelen DL, van Rood JJ, Claas FH.

J Reprod Immunol. 2009 Nov;82(2):148-57. doi: 10.1016/j.jri.2009.05.003. Epub 2009 Jul 23.

PMID:
19631389
25.

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

Hahn T, McCarthy PL Jr, Zhang MJ, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Litzow M, Anasetti C, Pavletic S, Ringdén O.

J Clin Oncol. 2008 Dec 10;26(35):5728-34. doi: 10.1200/JCO.2008.17.6545. Epub 2008 Nov 3.

26.

Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity.

Griffioen M, van der Meijden ED, Slager EH, Honders MW, Rutten CE, van Luxemburg-Heijs SA, von dem Borne PA, van Rood JJ, Willemze R, Falkenburg JH.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3837-42. doi: 10.1073/pnas.0712250105. Epub 2008 Mar 3.

27.

Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development.

Feitsma AL, Worthington J, van der Helm-van Mil AH, Plant D, Thomson W, Ursum J, van Schaardenburg D, van der Horst-Bruinsma IE, van Rood JJ, Huizinga TW, Toes RE, de Vries RR.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19966-70. Epub 2007 Dec 6.

28.

Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?

van Rood JJ, Oudshoorn M.

Bone Marrow Transplant. 2008 Jan;41(1):1-9. Epub 2007 Nov 5.

PMID:
17982505
29.

Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.

van der Burg SH, Piersma SJ, de Jong A, van der Hulst JM, Kwappenberg KM, van den Hende M, Welters MJ, Van Rood JJ, Fleuren GJ, Melief CJ, Kenter GG, Offringa R.

Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12087-92. Epub 2007 Jul 5.

30.

Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation.

Heemskerk MB, Cornelissen JJ, Roelen DL, van Rood JJ, Claas FH, Doxiadis II, Oudshoorn M.

Bone Marrow Transplant. 2007 Aug;40(3):193-200. Epub 2007 May 28.

PMID:
17529995
31.

A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques.

Doxiadis GG, de Groot N, Claas FH, Doxiadis II, van Rood JJ, Bontrop RE.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):8907-12. Epub 2007 May 14.

32.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group.

Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36.

33.

No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals.

van den Boogaardt DE, van Miert PP, Koekkoek KM, de Vaal YJ, van Rood JJ, Claas FH, Roelen DL.

Hum Immunol. 2005 Dec;66(12):1203-12. Epub 2006 Mar 24.

PMID:
16690407
34.

The influence of inherited and noninherited parental antigens on outcome after transplantation.

van den Boogaardt DE, van Rood JJ, Roelen DL, Claas FH.

Transpl Int. 2006 May;19(5):360-71. Review.

35.

Reactivation by exon shuffling of a conserved HLA-DR3-like pseudogene segment in a New World primate species.

Doxiadis GG, van der Wiel MK, Brok HP, de Groot NG, Otting N, 't Hart BA, van Rood JJ, Bontrop RE.

Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5864-8. Epub 2006 Mar 31.

36.

Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response.

Heemskerk MB, Roelen DL, Dankers MK, van Rood JJ, Claas FH, Doxiadis II, Oudshoorn M.

Hum Immunol. 2005 Sep;66(9):969-76. Epub 2005 Oct 10.

PMID:
16360836
37.

ABO blood group barrier in allogeneic bone marrow transplantation revisited.

Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringdén O, Barrett AJ; GVHD Working Committee of Center for International Blood and Marrow Transplant Research.

Biol Blood Marrow Transplant. 2005 Dec;11(12):1006-13.

38.

Differential immunogenicity of HLA mismatches in clinical transplantation.

Claas FH, Dankers MK, Oudshoorn M, van Rood JJ, Mulder A, Roelen DL, Duquesnoy RJ, Doxiadis II.

Transpl Immunol. 2005 Aug;14(3-4):187-91. Epub 2005 Apr 25. Review.

PMID:
15982562
39.

The effect of noninherited maternal antigens in allogeneic transplantation.

van Rood JJ, Roelen DL, Claas FH.

Semin Hematol. 2005 Apr;42(2):104-11. Review.

PMID:
15846576
40.

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!

Heemskerk MB, van Walraven SM, Cornelissen JJ, Barge RM, Bredius RG, Egeler RM, Tj Lie JL, Révész T, Sintnicolaas K, Wulffraat NM, Donker AE, Hoogerbrugge PM, van Rood JJ, Claas FH, Oudshoorn M.

Bone Marrow Transplant. 2005 Apr;35(7):645-52.

PMID:
15723086
41.

Unparalleled complexity of the MHC class I region in rhesus macaques.

Otting N, Heijmans CM, Noort RC, de Groot NG, Doxiadis GG, van Rood JJ, Watkins DI, Bontrop RE.

Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1626-31. Epub 2005 Jan 21.

42.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM.

N Engl J Med. 2004 Nov 25;351(22):2265-75.

43.

Women, pregnancy and serendipity: a personal story about the discovery of HLA.

Van Rood JJ.

J Nephrol. 2004 May-Jun;17(3):467-74.

PMID:
15365974
44.

Weighing optimal graft survival through HLA matching against the equitable distribution of kidney allografts.

van Rood JJ.

N Engl J Med. 2004 Feb 5;350(6):535-6. No abstract available.

PMID:
14762177
45.

The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.

Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, Spaenij L, Koning F.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12390-5. Epub 2003 Oct 6.

46.

The World Marrow Donor Association (WMDA): its goals and activities.

Gahrton G, van Rood JJ, Oudshoorn M; World Marrow Donor Association (WMDA).

Bone Marrow Transplant. 2003 Jul;32(2):121-4.

PMID:
12838274
47.

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.

Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA, van Luxemburg-Heys SA, Hoogeboom M, Mutis T, Drijfhout JW, van Rood JJ, Willemze R, Falkenburg JH.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2742-7. Epub 2003 Feb 24.

48.

On the clinical importance of privileged sites.

van Rood JJ.

Hum Immunol. 2002 Oct;63(10):799-804. No abstract available.

PMID:
12368031
49.

Evidence for an ancient selective sweep in the MHC class I gene repertoire of chimpanzees.

de Groot NG, Otting N, Doxiadis GG, Balla-Jhagjhoorsingh SS, Heeney JL, van Rood JJ, Gagneux P, Bontrop RE.

Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11748-53. Epub 2002 Aug 19.

50.

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

van Rood JJ, Loberiza FR Jr, Zhang MJ, Oudshoorn M, Claas F, Cairo MS, Champlin RE, Gale RP, Ringdén O, Hows JM, Horowitz MH.

Blood. 2002 Mar 1;99(5):1572-7.

Supplemental Content

Loading ...
Support Center